Ten Largest Investments
Summary by AI BETAClose X
JPMorgan India Growth & Income PLC has announced its ten largest investments as a percentage of total assets as of July 31, 2026, with Icici Bank Ltd representing 9.3% and Hdfc Bank Ltd at 7.9%. Other significant holdings include Bajaj Finance Ltd at 5.4%, Kotak Mahindra Bank Ltd at 4.8%, and Mahindra & Mahindra Ltd at 4.6%. Bharti Airtel accounts for 4.4%, Reliance Industries Ltd for 4.2%, and Infosys Technologies Adr for 3.4%. Cholamandalam Investment and Finance Co Ltd holds 3.0%, and Dr Reddy's Laboratories Ltd is at 2.9%. These top ten investments collectively represent 49.9% of the Company's total assets, excluding liquidity stocks.
JPMorgan India Growth & Income PLC
13 August 2026
|
JPMORGAN INDIA GROWTH & INCOME PLC (the 'Company') |
|
|
Legal Entity Identifier: 549300OHW8R1C2WBYK02 |
|
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 July 2026 |
|
|
Icici Bank Ltd |
9.3% |
|
Hdfc Bank Ltd |
7.9% |
|
Bajaj Finance Ltd |
5.4% |
|
Kotak Mahindra Bank Ltd |
4.8% |
|
Mahindra & Mahindra Ltd |
4.6% |
|
Bharti Airtel |
4.4% |
|
Reliance Industries Ltd |
4.2% |
|
Infosys Technologies Adr |
3.4% |
|
Cholamandalam Investment and Finance Co Ltd |
3.0% |
|
Dr Reddy'S Laboratories Ltd |
2.9% |
|
Total |
49.9% |
|
Excludes Investments in Liquidity stocks |
|
|
Name of contact and telephone number for queries: |
|
|
Paul Ainger 0044 207 742 6524 |
|
|
Name of authorised company official responsible for making this notification: |
|
|
Graham Fenwick 020 7742 4000 - Company Secretary |
|
|
Date: 13 August 2026 |
|
|
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 hour ago Schroder Income Growth Fund
- 2 hours ago Oberon AIM VCT
- 2 hours ago Johnson Matthey
- 2 hours ago Sirius Real Estate Ltd.
- 3 hours ago GSK